RAD51 and colorectal carcinoma: In such context, one study revealed that RAD51 targeting improves the vulnerability of CRC stem cells to the CHK1/2 inhibitor prexasertib and annihilates them through triggering mitotic catastrophe by the caspase-dependent mechanism [131].